Literature DB >> 24560753

Modeling positioning uncertainties of prostate cancer external beam radiation therapy using pre-treatment data.

Per Munck af Rosenschöld1, Neil B Desai2, Jung Hun Oh3, Aditya Apte3, Margie Hunt3, Abraham Kalikstein2, James Mechalakos3, Laura Happersett3, Joseph O Deasy3, Michael J Zelefsky4.   

Abstract

PURPOSE: To investigate the influence of treatment plan data and image guidance (IG) on positioning uncertainty during prostate cancer (PCa) radiotherapy (RT).
METHODS: Body mass index (BMI), planning target volume (PTV), bladder volume (BV), and rectal cross section area (RCS) were collected for 267 consecutive PCa patients undergoing daily IGRT. Radiographic isocenter corrections to intra-prostatic fiducials for 12,490 treatment fractions were used to derive random (RE) and systematic (SE) inter-fraction uncertainties for the cardinal axes. These data were used to simulate RE and SE for weekly IG and Action Level (AL)-IG treatment protocols.
RESULTS: SE and RE were 2-5 and 3-4mm in the cardinal axes, respectively, during simulation of no IG. Without IG, positive correlations (p<0.01) were noted for (1) anterior-posterior RE vs. RCS and BV and (2) cranio-caudal RE vs. RCS, BV and BMI. The RE increase was 3mm for the highest quartile of RCS, BV and BMI. Daily IGRT eliminated this relationship. 3D IG corrections of 1cm or more occured in 27% of treatment fractions and in 97% of patients.
CONCLUSION: PCa patients with elevated pre-treatment BV, RCS and BMI have increased inter-fractionation positioning uncertainty and appear the primary candidates for daily IGRT.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  IGRT; Image guided radiotherapy; Interfraction motion; Prostate cancer

Mesh:

Year:  2014        PMID: 24560753      PMCID: PMC4822486          DOI: 10.1016/j.radonc.2013.12.010

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  21 in total

1.  Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer.

Authors:  Uulke A van der Heide; Alexis N T J Kotte; Homan Dehnad; Pieter Hofman; Jan J W Lagenijk; Marco van Vulpen
Journal:  Radiother Oncol       Date:  2006-12-04       Impact factor: 6.280

2.  X-ray-assisted positioning of patients treated by conformal arc radiotherapy for prostate cancer: comparison of setup accuracy using implanted markers versus bony structures.

Authors:  Guy Soete; Mieke De Cock; Dirk Verellen; Dirk Michielsen; Frans Keuppens; Guy Storme
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-29       Impact factor: 7.038

3.  A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy.

Authors:  Helen A McNair; Vibeke N Hansen; Christopher C Parker; Phil M Evans; Andrew Norman; Elizabeth Miles; Emma J Harris; Louise Del-Acroix; Elizabeth Smith; Richard Keane; Vincent S Khoo; Alan C Thompson; David P Dearnaley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-08       Impact factor: 7.038

4.  Impact of body mass index on outcomes after conformal radiotherapy in patients with prostate cancer.

Authors:  Hans Geinitz; Reinhard Thamm; Tobias Mueller; Kerstin Jess; Frank B Zimmermann; Michael Molls; Carsten Nieder
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-09-23       Impact factor: 7.038

5.  Control, Correction, and Modeling of Setup Errors and Organ Motion.

Authors: 
Journal:  Semin Radiat Oncol       Date:  1995-04       Impact factor: 5.934

6.  Potential for higher treatment failure in obese patients: correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocenters in an analysis of 1,465 computed tomographic images.

Authors:  James R Wong; Zhanrong Gao; Scott Merrick; Paula Wilson; Minoru Uematsu; Kevin Woo; Chee-Wai Cheng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-10       Impact factor: 7.038

7.  Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.

Authors:  Michael J Zelefsky; Marisa Kollmeier; Brett Cox; Anthony Fidaleo; Dahlia Sperling; Xin Pei; Brett Carver; Jonathan Coleman; Michael Lovelock; Margie Hunt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-11       Impact factor: 7.038

8.  Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.

Authors:  Sean P Stroup; Jennifer Cullen; Brian K Auge; James O L'Esperance; Song K Kang
Journal:  Cancer       Date:  2007-09-01       Impact factor: 6.860

9.  Rectal filling at planning does not predict stability of the prostate gland during a course of radical radiotherapy if patients with large rectal filling are re-imaged.

Authors:  A L Stillie; T Kron; C Fox; A Herschtal; A Haworth; A Thompson; R Owen; K H Tai; G Duchesne; F Foroudi
Journal:  Clin Oncol (R Coll Radiol)       Date:  2009-10-04       Impact factor: 4.126

10.  Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer.

Authors:  Daniel E Spratt; Xin Pei; Josh Yamada; Marisa A Kollmeier; Brett Cox; Michael J Zelefsky
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-07-12       Impact factor: 7.038

View more
  4 in total

1.  Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.

Authors:  Lynsey Devlin; David Dodds; Azmat Sadozye; Philip McLoone; Nicholas MacLeod; Carolynn Lamb; Suzanne Currie; Stefanie Thomson; Aileen Duffton
Journal:  Br J Radiol       Date:  2020-01-30       Impact factor: 3.039

2.  Superiority of a soft tissue-based setup using cone-beam computed tomography over a bony structure-based setup in intensity-modulated radiotherapy for prostate cancer.

Authors:  Hiraku Sato; Eisuke Abe; Satoru Utsunomiya; Motoki Kaidu; Nobuko Yamana; Kensuke Tanaka; Atsushi Ohta; Mika Obinata; Junyang Liu; Gen Kawaguchi; Katsuya Maruyama; Fumio Ayukawa; Hidefumi Aoyama
Journal:  J Appl Clin Med Phys       Date:  2015-09-08       Impact factor: 2.102

3.  Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and improves biochemical control.

Authors:  Per Munck Af Rosenschold; Michael J Zelefsky; Aditya P Apte; Andrew Jackson; Jung Hun Oh; Elliot Shulman; Neil Desai; Margie Hunt; Pirus Ghadjar; Ellen Yorke; Joseph O Deasy
Journal:  Radiat Oncol       Date:  2018-04-12       Impact factor: 3.481

4.  Residual positioning errors and uncertainties for pediatric craniospinal irradiation and the impact of image guidance.

Authors:  Daniel Gram; André Haraldsson; N Patrik Brodin; Karsten Nysom; Thomas Björk-Eriksson; Per Munck Af Rosenschöld
Journal:  Radiat Oncol       Date:  2020-06-10       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.